Company intelligence / Profile preview

Pops Diabetes Care

Oak Park Heights, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Pops Diabetes Care has commercialized an FDA‑cleared integrated glucose meter (Rebel) connected to a mobile app and AI virtual coach (Mina) as part of the Pops Self-care Platform, which has been clinically validated for 100% accuracy to the latest FDA meter standard and is reported in published studies to lower and sustain A1c reductions over 24 months.[1][2][4][7][10]

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapyDigital therapeutic
Industry: Physiological Monitoring

Partnerships

imaware (at‑home lab tests for A1c and heart health)[2][4]Vous Vitamin (personalized vitamins for people with diabetes)[2][4]Employer and health plan partners providing Pops Rebel system at no cost to members[10]

Beyond the preview

Go deeper on Pops Diabetes Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pops Diabetes Care.

Explore the full profile